Analyzing TP53 and PIK3CA mutation frequencies in the CMs of BC cases diagnosed at early stages (I-II) versus those diagnosed at advanced stages (III-IV), we observed that they were very similar. This evidence concerns the gene PIK3CA and breast cancer.